Rhythm Pharmaceuticals (RYTM) Short Interest
Nasdaq • RYTM • US76243J1051
As of Nov 3, 2026, ORTEX estimates 18.7% of free float is sold short, 10.2 days to cover, cost to borrow 0.43%.
Nasdaq • RYTM • US76243J1051
As of Nov 3, 2026, ORTEX estimates 18.7% of free float is sold short, 10.2 days to cover, cost to borrow 0.43%.
This page tracks how heavily Rhythm Pharmaceuticals (Nasdaq:RYTM) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Rhythm Pharmaceuticals (Nasdaq: RYTM) has a market capitalization of $7.67B. Last close $110.68 (as of 2026-11-05); 52-week range $74.50 to $122.20. ORTEX data as of 2026-11-03: short interest is 18.67% of free float, 10.2 days to cover and the average cost to borrow is 0.43%.